CA2642575C - Quantitation of cellular dna and cell numbers using element labeling - Google Patents
Quantitation of cellular dna and cell numbers using element labeling Download PDFInfo
- Publication number
- CA2642575C CA2642575C CA2642575A CA2642575A CA2642575C CA 2642575 C CA2642575 C CA 2642575C CA 2642575 A CA2642575 A CA 2642575A CA 2642575 A CA2642575 A CA 2642575A CA 2642575 C CA2642575 C CA 2642575C
- Authority
- CA
- Canada
- Prior art keywords
- cells
- dna
- sample
- cell
- intercalator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091092356 cellular DNA Proteins 0.000 title abstract description 6
- 238000002372 labelling Methods 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 34
- 238000000921 elemental analysis Methods 0.000 claims abstract description 29
- 239000000138 intercalating agent Substances 0.000 claims description 33
- 239000000427 antigen Substances 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 29
- 239000002253 acid Substances 0.000 claims description 3
- 238000009616 inductively coupled plasma Methods 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 47
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 abstract description 18
- 238000004458 analytical method Methods 0.000 abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 8
- 239000012625 DNA intercalator Substances 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 148
- 239000010948 rhodium Substances 0.000 description 52
- 239000000523 sample Substances 0.000 description 52
- 239000012491 analyte Substances 0.000 description 46
- 239000000047 product Substances 0.000 description 40
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 15
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 14
- 239000010931 gold Substances 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000027455 binding Effects 0.000 description 10
- 238000009739 binding Methods 0.000 description 10
- 238000009830 intercalation Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 229910052703 rhodium Inorganic materials 0.000 description 8
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 7
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 7
- 239000003599 detergent Substances 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 229940104230 thymidine Drugs 0.000 description 7
- 230000001052 transient effect Effects 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 230000022131 cell cycle Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 6
- 229910052761 rare earth metal Inorganic materials 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000018486 cell cycle phase Effects 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 150000002910 rare earth metals Chemical group 0.000 description 5
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 5
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
- 230000018199 S phase Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 229960004279 formaldehyde Drugs 0.000 description 4
- 230000002687 intercalation Effects 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 230000000394 mitotic effect Effects 0.000 description 4
- 229950006344 nocodazole Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000004568 DNA-binding Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 3
- KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000019256 formaldehyde Nutrition 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 229910052747 lanthanoid Inorganic materials 0.000 description 3
- 150000002602 lanthanoids Chemical class 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000011278 mitosis Effects 0.000 description 3
- 230000008823 permeabilization Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 150000003624 transition metals Chemical class 0.000 description 3
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 230000010190 G1 phase Effects 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- 108091061960 Naked DNA Proteins 0.000 description 2
- 108010047956 Nucleosomes Proteins 0.000 description 2
- 101710160107 Outer membrane protein A Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000000559 atomic spectroscopy Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229910052729 chemical element Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 210000001623 nucleosome Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- ASBFNPBREVZDOE-UHFFFAOYSA-N phenanthrene-9,10-diimine Chemical compound C1=CC=C2C(=N)C(=N)C3=CC=CC=C3C2=C1 ASBFNPBREVZDOE-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- -1 sulfonic acid anion Chemical class 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical class [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZRZHXNCATOYMJH-UHFFFAOYSA-N 1-(chloromethyl)-4-ethenylbenzene Chemical compound ClCC1=CC=C(C=C)C=C1 ZRZHXNCATOYMJH-UHFFFAOYSA-N 0.000 description 1
- 238000010600 3H thymidine incorporation assay Methods 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 102000013925 CD34 antigen Human genes 0.000 description 1
- 108050003733 CD34 antigen Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000002112 DNA intercalation Effects 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 229940122029 DNA synthesis inhibitor Drugs 0.000 description 1
- 101001042083 Entamoeba histolytica Amoebiasin-1 Proteins 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 230000004668 G2/M phase Effects 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 229940121849 Mitotic inhibitor Drugs 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 208000037280 Trisomy Diseases 0.000 description 1
- 206010053871 Trisomy 8 Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 1
- 101100175600 Zea mays SH2 gene Proteins 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- SMNPLAKEGAEPJD-UHFFFAOYSA-N chembl34922 Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(NC(=N2)C=3C=C4N=C(NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 SMNPLAKEGAEPJD-UHFFFAOYSA-N 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229960000587 glutaral Drugs 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000000190 proton-induced X-ray emission spectroscopy Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- PZSJYEAHAINDJI-UHFFFAOYSA-N rhodium(3+) Chemical compound [Rh+3] PZSJYEAHAINDJI-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000034298 trisomy chromosome 8 Diseases 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000004876 x-ray fluorescence Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Methods and kits for the quantitation of cellular DNA and cell numbers are provided. Passive element uptake, element-labeled DNA intercalators, and element labeled affinity reagents are used to quantify DNA and cells. The DNA and the cells are analyzed by elemental analysis, including ICP-MS. The methods and kits provide a fast and accurate analysis of cellular DNA and cell numbers.
Description
QUANTITATION OF CELLULAR DNA AND CELL NUMBERS USING
ELEMENT LABELING
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to United States Provisional Patent Application No. 60/772,589 filed February 13,2006, entitled "Quantitation of cell numbers and cell size using metal labeling and eleme-ntal mass spectrometry.
COPYRIGHT AND LEGAL NOTICES
A portion of the disclosure of this patent document contains material which is subject to copyright pro-tection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or re-cords, but otherwise reserves all copyrights whatsoever.
FIELD
[0001] The invention relates to a rapid and sensitive assay employing elemental analysis for cell enumeration and cell proliferation using element-labeled intercalators together with element-tagged affinity reagents to determine the cell type in a mixed cell population.
INTRODUCTION
ELEMENT LABELING
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to United States Provisional Patent Application No. 60/772,589 filed February 13,2006, entitled "Quantitation of cell numbers and cell size using metal labeling and eleme-ntal mass spectrometry.
COPYRIGHT AND LEGAL NOTICES
A portion of the disclosure of this patent document contains material which is subject to copyright pro-tection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or re-cords, but otherwise reserves all copyrights whatsoever.
FIELD
[0001] The invention relates to a rapid and sensitive assay employing elemental analysis for cell enumeration and cell proliferation using element-labeled intercalators together with element-tagged affinity reagents to determine the cell type in a mixed cell population.
INTRODUCTION
[0002] "Intercalation" is functional non-covalent insertion of a ligand between two molecular moieties. For example, the molecular moieties can be nucleotide base units of double-stranded nucleic acid' or amino acids in proteins, to name a few. DNA intercalating reagents are extensively used as sensitive molecular probes and therapeutic agents owing to their site selective targeting and reactivi-ty". Metallointercalators are intercalating reagents having a transition-metal complex core. Metalloin-tercalators can be bound by non-intercalating and intercalating ligands. For example, metallointercala-tors can be bound by two non-intercalating ligands and one intercalating ligand. The intercalator can comprise other elements (i.e. non-metal elements, such as propidium iodide with two iodide mole-cules) for DNA quantitation. "Elemental analysis" is a process where a sample is analyzed for its ele-mental composition and sometimes isotopic composition. Elemental analysis can be accomplished by a number of methods, including, but not limited to: I. optical atomic spectroscopy, such as flame atomic absorption, graphite furnace atomic absorption, and inductively coupled plasma atomic emission, which probe the outer electronic structure of atoms; II. mass spectrometric atomic spectroscopy, such as inductively coupled plasma mass spectrometry, which probes the mass of atoms; III. X-ray fluores-cence, particle induced x-ray emission, x-ray photoelectron spectroscopy, and Auger electron spectros-copy which probes the inner electronic structure of atoms.
[0003] "Elemental analyzer" is an instrument functionally designed for the quanfitation of atomic composition of a sample employing one of the methods of elemental analysis.
[0004] "Particle elemental analysis" is a process where an analyzed sample, composed of par-ticles dispersed in a liquid (beads in buffer, for example), is interrogated in such manner that the atomic composition is recorded for individual particles (bead-by-bead, for example).
An example of the ana-lytical instrument is a mass spectrometer-based flow cytometer.
An example of the ana-lytical instrument is a mass spectrometer-based flow cytometer.
[0005] "Solution elemental analysis" is a process where an analyzed sample is interrogated in such manner that the atomic composition is averaged over the entire solution of the sample.
[0006] "Element tag" or "tag" is a chemical moiety which includes an elemental atom or multi-tude of elemental atoms with one or many isotopes attached to a supporting molecular structure. In one instance an element tag may comprise a metal-chelate polymer with an attachment group. The attach-ment group may include, but is not limited to, pyrrole-2,5-dione (maleimido), sulfonic acid anion, or p-(chloromethyl)styrene (for thiol, N-terminus, or C-terminus, respectively).
Other means are known to those skilled in the art.
Other means are known to those skilled in the art.
[0007] The term "antibody" includes monoclonal antibodies, polyclonal antibodies, multispeci-1 5 fic antibodies (e.g. dual specificity antibodies), and antibody fragments, both natural and recombinant, as long as they exhibit the desired biological activity or something functionally similar.
[0008] An "antigen specific antibody labeled with an element tag"
comprises an antibody which has been subsequently reacted with an element tag which allows the antigen-antibody complex to be detected and quantified by solution elemental analysis.
comprises an antibody which has been subsequently reacted with an element tag which allows the antigen-antibody complex to be detected and quantified by solution elemental analysis.
[0009] An "affinity product" or "affinity reagent" refers to biological molecules (antibody, ap-tamer, lectin, sequence-specific binding peptide, etc) which are known to form highly specific non-covalent bonds with respective target molecules (peptides, antigens, small molecules, etc). Affinity re-agent labeled with a unique element tag is an affinity product labeled with an element tag that is unique and distinguishable from a multitude of other element tags in the same sample.
[00101 A "transition element" means any element having the following atomic numbers, 21-29, 39-47, 57-79, and 89. Transition elements include the rare earth elements, lanthanides, and noble metals (Cotton and Wilkinson, 1972).
[0011] An "internal standard" is defined as a known amount of a compound, different from analyte, that is added to the unknown. Signal from analyte is compared with signal from the internal standard to find out how much analyte is present. An internal standard normally is used when perform-ing mass spectrometry quantitation. An internal standard can also be used by other means known to those skilled in the art.
[0012] Fixing and permeabilization refers to chemical cross-linking of cellular components by agents known to those skilled in the art, and may include but not limited to glutaraldehyde, formalde-hyde, formalin, ethanol, methanol, etc., and creating holes in the cell membrane with detergents. Suit-able detergents may be readily selected from among non-ionic detergents. These detergents may be used at a concentration between about 0.001% to about 0.1%. One currently preferred detergent is Tri-tonTs4 X-100 (Sigma T9284). Examples of other suitable detergents include Igepal0 and Nonidet P-40. Other suitable detergents may be readily selected by one of skill in the art.
[0013] It is accepted in cell biology that the content of nucleic acids is a reasonable indicator of cell number owing to the tight regulation of DNA and RNA levels in the cells.
DNA measurement is commonly used to estimate the number of cells in solid tumors as well as to characterize hematopoiet-ic malignancies and monitor chemotherapy treatmene's. Many studies demonstrate the prognostic sig-nificance of ploidy in human tumors. For example, trisomy 8 is one of the most frequent numerical chromosomal abnormalities observed in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)6. The content of DNA also reflects cell cycle progression.
Cells grow through mito-sis and the individual cells can be identified or classified, through their progression by mitosis, with a determination of the amount of DNA in the cell. In combination with antigen identification, the meas-urement of DNA indicates the ploidy or cell cycle phase for a subset of cells defined by the antigen in heterogeneous cell populations, or the distribution of a particular antigen through the cell cycle's.
[0014] Reagents that measure cell proliferation and cell numbers are important diagnostic and research tools. Standard methods of cell enumeration include BrdU (5-bromo-2'-deoxyuridine); 3H-thymidine incorporation into replicating cells during proliferation, and the measurement of total nucle-ic acid content of lysed cells with a calorimetric (diphenylamine) reagent.
Fluorescent DNA intercalat-ing dyes in conjunction with flow cytometry have become the method of choice for rapid cell cycle and cell number measurements. Such DNA binding dyes as Hoechst 332589, propidium iodide , DAPIII and acridine orange" have been shown in many applications to accurately estimate cell num-bers. However, these reagents suffer from relatively low fluorescence enhancements upon binding nu-cleic acids, low extinction coefficients and have high intrinsic background fluorescence. Recently, a novel class of cyanine dyes and a sensitive nucleic acid stain-based assay have been developed by Mo-lecular Probes Inc. which obviates these problems".
[0015] Metallointercalators interact with double-stranded DNA through electrostatic forces--groove binding and intercalation, for example. Substantial research has been devoted to the photolumines-Cent14-16 and photo-oxidizing properties of metallointercalators17-21. 9,10-Phenanthrenequinone diimine (phi) complexes of rhodium(III) (Rh(III)) have been shown to bind tightly (Kd 40-8M) to double stranded DNA by intercalation in the major groove22-24 and undergo a variety of photoinduced reac-tions with DNA20'23-23. From photofootprinting experiments Barton et al.
(1992) concluded that Rh(phi)2(bpy)3+ has a rigid rhodium complex that can occupy directly all sites not obstructed by DNA
binding proteins, and at rhodium/base pair ratios of 2:1 binding to DNA is sequence neutral and ran-dom28'29. Recent work from the same group has also shown that metallointercalators which targeted major groove sites bind poorly to double-stranded RNA3631. However, other experiments indicate that the apposition of several non-canonical bases as well as stem-loop junctions and bulges in tRNA could result in intimately stacked structures with opened major grooves accessible for metallointercalator [0016] Recently, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) has been intro-duced to the field of protein and cell surface antigen identification via ICP-MS-linked immunoassays using metal containing immunoreagents such as gold and lanthanide-conjugated antibodies32-35. ICP-1 0 MS as an analytical detector offers absolute quantification that is largely independent of the analyte mo-lecular form or sample matrix. Secondly, the abundance sensitivity of ICP-MS, a measure of the over-lap of signals of neighboring isotopes, is large (>106 for the quadrupole analyzer), and this ensures inde-pendence of the detection channels over a wide dynamic range. The third key property is that ICP-MS
is very sensitive; it was demonstrated that ICP-MS-linked immunoassays can be at least as sensitive as radioimrnunoassay.
[0017] ICP-MS is extensively used to study natural and induced metal incorporation into bacte-ria36-39, plants4 and as a tool in metalloproteomics research'''.
[0018] The choice of the element to be employed in the methods of the present invention is preferably selected on the basis of its natural abundance in the sample under investigation and whether the element is cytotoxic to the sample under investigation.
[0019] Most metals of the transition and rare earth groups are anticipated for use in passive uptake labeling of cultured cells. It is wise to choose elements that have low or no cytotoxicity and have a low abundance in growth media and biological samples. For example, vanadium and mercury can be toxic to certain cells, while Fe, Cu and Zn can be present in high concentrations in some cell culture media. On the other hand, Pr, Ho, Tb, La, for example are normally well tolerated by mammalian cells and are not abundant in the environment.
[0020] Metallointercalators are synthesized using aromatic compounds as ligands for DNA
binding and transition-metal complex cores. Metallointercalators can incorporate many types of metal centers such as Ru, Rh, Os, Co, Re, and Jr. A vast number of ligands are known to those skilled in the art (bipyridine, 9,10-phenanthrene quinone diimine, 1,10-phenanthroline, etc).
Other element labeled DNA intercalators can also be used.
[0021] An unusual isotope composition of the tag element can be used in order to distinguish between naturally present elements in the sample and the tag material. It is advantageous if the relative abundance of the tag elements is sufficiently different from the relative abundance of elements in a given sample under analysis. By "sufficiently different" it is meant that under the methods of the pre-sent invention it is possible to detect the target elemental tag over the background elements contained in a sample under analysis. Indeed, it is the difference in inter-elemental ratios of the tagging elements and the sample matrix that can be used advantageously to analyze the sample.
[0022] It is feasible to select elemental tags, which do not produce interfering signals during analysis (i.e. do not have over-lapping signals due to having the same mass).
Therefore, two or more analytical determinations can be performed simultaneously in one sample.
Moreover, because the ele-mental tag can be made containing many copies of the same atoms, the measured signal can be greatly amplified.
SUMMARY
[0023] These and other features of the applicant's teachings are set forth herein. An aspect of the applicant's teachings is to provide a method to quantify the number of cells in a sample comprising cells, the method comprising: culturing the sample with an element to passively accumulate the element in the cells in the sample; washing the cells to remove non-accumulated element; measuring the element 1 5 in a known quantity of the cells by elemental analysis to determine the amount of accumulated element per cell; measuring the element in the sample by elemental analysis; and quantifying the number of cells in the sample.
[0024] Another aspect of the applicant's teachings is to provide a method to quantify antigen content per cell in a cell sample wherein the cells of the sample comprise an antigen, comprising: cultur-ing the cells of the sample in the presence of a first element wherein the cells passively accumulate the first element; calculating the number of cells in the sample; removing non-accumulated first element;
incubating the cells with antigen specific affinity products labeled with a second element tag; removing unbound affinity products; simultaneously measuring the passively accumulated first element and the amount of the bound affinity product labeled with a second element tag by elemental analysis; and cal-culating the antigen content per cell.
[0025] Another aspect of the applicant's teachings is to provide a method for determining the phase of a cell cycle in a sample of cells, comprising: determining the number of cells in the sample;
fixing and permeabilizing the cells; exposing the sample of cells to an element containing intercalator under conditions appropriate to incorporate the intercalator into the DNA
within the cells of the sample.
removing unbound intercalator; measuring the content of the labeled DNA within the cells by elemental analysis of the element; determining the amount of DNA per cell; and determining the phase of the cell cycle from the amount of DNA per cell.
[0026] Another aspect of the applicant's teachings is to provide a method to determine DNA
content and antigen content per cell in a sample of cells, comprising:
determining the number of cells in the sample; fixing and permeabilizing the cells; incubating the sample of cells with an intercalator tagged with a first element under conditions appropriate to incorporate the intercalator into the DNA
within the cells of the sample; removing unbound intercalator from the cells;
incubating antigen specific affinity products labeled with a second element tag with the cells; removing unbound affinity products from the cells; simultaneously measuring the intercalator and the affinity product labeled with the sec-ond element tag by elemental analysis; and calculating the DNA content and antigen content per cell.
[0027] Another aspect of the applicant's teachings is to provide a kit for the detection and measurement of a first element in a sample, where the measured first element originated from the first element passively accumulated by cells, comprising: (a) a soluble compound of a first element for addi-1 0 tion to a cell media. The kit can further comprise instructions for (i) spiking a cell media with the solu-ble compound of the first element, ii) separating bound first element from unbound first element, and iii) detecting and measuring the passively accumulated first element by elemental analysis. The kit can fur-ther comprise (a) a second element for directly tagging an analyte specific affinity product; and (b) an analyte specific affinity product. The kit can further comprise instructions for (i) directly tagging the 1 5 analyte specific affinity product with the second element; (ii) combining the tagged analyte specific af-finity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra-or/and extra-cellular analyte and analyte complex, (iii) separating bound affinity product from unbound affinity product, and iv) detecting and measuring the second element by elemental analysis. The kit can further comprise an analyte spe-20 cific affinity product, wherein the analyte specific affinity product is directly tagged with a second ele-ment.
[00281 Another aspect of the applicant's teachings is to provide a kit for the detection and measurement of a first element in a sample, where the measured first element originated from a DNA
intercalator, comprising: (a) a DNA intercalator comprising a first element.
The kit can further compris-2 5 ing instructions for i) incorporating the first element containing intercalator into the DNA within the cells of the sample, ii) separating bound intercalator from unbound intercalator, and iii) detecting and measuring the intercalator comprising the first element by elemental analysis.
The kit can further com-prise (a) a second element for directly tagging an analyte specific affinity product; and (b) an analyte specific affinity product. The kit can further comprise instructions for (i) directly tagging an analyte 30 specific affinity product; (ii) combining the tagged analyte specific affinity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra- or/and extra-cellular analyte and analyte complex, (iii) separat-ing bound affinity product from unbound affinity product, and iv) detecting and measuring the second element by elemental analysis. The kit can further comprise an analyte specific affinity product wherein 35 the analyte specific affinity product is directly tagged with a second element.
BRIEF DESCRIPTION OF THE FIGURES
[0029] Figure 1A. Upper plot - linear response between number of KG-la cells present in each sample and amount of CD34 antigen detected as signal from Eu normalized to Ir internal standard (Eu/Ir) with background subtracted. Lower plot ¨ relationship of KG-la cell numbers and accumulated metal, palladium, normalized to Jr internal standard (Pd/1r).
[0030] Figure 1B. Upper bar graph ¨ mixed cell samples ( lo,2o,3o,4o,5o,7o on the Y ¨axis) were incubated with negative control isotype specific immunoglobulin and Eu-labeled secondary anti-bodies; analyzed for Eu, Pd, and Rh; signal values are relative to Jr internal standard. Lower bar graph ¨
samples (#1, #2, #3, #4, #5, #7 on the Y-axis) were incubated with anti-CD34 primary and Eu-labeled secondary antibodies; analyzed for Eu, Pd, and Rh; signal values are relative to Jr internal standard.
[0031] Figure 2. Linear concentration dependence between amounts of Rh(III) metalointercala-tor and signal obtained from treated cells (normalized response).
[0032] Figure 3. Normalized response for Rh obtained after treating live, or fixed, or fixed/permeabilized (fix/perm) MBA-1 cells with Rh(III) complex.
1 5 [0033] Figure 4. Simultaneous identification of cellular DNA
(Rh) and surface antigen CD33 (Eu) by solution elemental analysis. MBA-1 cells were treated with Rh(III) complex and reacted with anti-CD33 antibodies followed by Eu-labeled secondary antibodies. Sample #1 contains 3x104, sample #2 - 3x105, and sample #3 - 3x106 cells.
[0034] Figure 5. Detection of the internal Rh(III) labels (A) and the surface Au labels (B) by particle elemental analysis with ICP-MS operated in transient mode. Single cell analysis of surface an-tigen CD34 expression (Au) and intracellular DNA (Rh) content were analyzed.
KG-la cells were treated with intercalator and reacted with anti-CD34 antibodies followed by Au-labeled secondary anti-bodies.
[0035] Figure 6. DNA content (Rh, normalized response) depending on cell cycle phase. K562 cells were grown under normal conditions (UN) or treated for synchronization in the mitotic (M) or syn-thetic (Gl/S) phase. Fixed cells were stained with Rh(III) complex and analyzed non-treated (non) or digested in Proteinase K (P) or RNAse A (R) solutions.
[0036] Figure 7. Chart showing a method to quantify antigen content per cell, in accordance with the invention.
[0037] Figure 8. Chart showing a method for determination of cell cycle phase, in accordance with the invention.
[0038] Figure 9. Chart showing a method to determine DNA and antigen content per cell, in accordance with the invention.
DESCRIPTION OF THE VARIOUS EMBODIMENTS
[0039] Aspects of the applicant's teachings may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teachings in any way.
[0040] Experiment I.
[0041] One embodiment can be demonstrated by example of rhodium (Rh) and palladium (Pd) in mixed cell populations with surface marker identified by europium (Eu). The experiment was set up to investigate if metals passively accumulated by cells could be indicative of cell number and cell type.
A work flow chart is presented in Figure 7. For this purpose two different leukemia cell lines were cul-tured for 72 hours in growth media supplemented with very low amounts of rare earth metals: 100ppb Rh was added to MBA-1 cells, and 500 ppb Pd was added to KG-la cells which express the cell surface marker. During the three days of cell culture, aliquots of cells were tested for viability with trypan blue.
1 5 No excessive cell death was recorded due to the presence of metals in media. Cells were collected by centrifugation (1200 rpm, 10 minutes), washed once in PBS/10%FBS and counted in a hemocytometer.
Serial dilutions were prepared to give 1 x106, 0.5 x106, 1 x105, 1 x104, 1 x103, and 1 x102 KG-la cells in a population of MBA-1 cells (1x106) per tube in triplicates (Tablel). In this example Pd will reflect the number of KG-la cells and the presence of surface marker CD34 will specify the cell type, while MBA-1 cells are marked by Rh. Immunolabeling was carried out by adding anti-CD34 antibodies to tubes containing decreasing amounts of live KG-la cells and incubating for 45 minutes on ice. Negative con-trol tubes were reacted with the IgG1 isotype control immunoglobulins. After three low speed centrifu-gation washes with PBS/10%FBS all samples were incubated with biotinylated anti-mouse antibodies.
This was followed by several washes, and Eu-labeled streptavidin (DELFIA, Perkin Elmer) was added to all samples as the last step in the immunolabeling procedure. Unreacted Eu-strepavidin was elimi-nated by three final washes. Cell pellets were then dissolved overnight in 75u1 of concentrated HC1.
Prior to ICP-MS analysis, an equal volume of lppb iridium standard (Ir) was added to each sample.
Three independent experiments were performed. ICP-MS acquisition of Eu, Rh and Pd signals are pre-sented in Figure 1A and Figure 1B. In this example, the detection limit for an abundant biomarker (CD34) is ¨1000 cells in the presence of 1x106 unrelated cells. Therefore, passive metal accumulation by cells can be used for normalization of a biomarker concentration in solution and particle elemental analysis.
[0042] Table 1. Samples containing mixed populations of cells cultured in media supplemented with palladium (Pd) or rhodium (Rh).
Sample KG1-a (Pd) MBA-1 (Rh) #1, lo 1e6 0 #2,2o 5e5 5e5 #3,3o 1e5 1e6 #4,4o 1e4 1e6 #5,5o 1e3 1e6 #7,7o 0 1e6 [0043] Although antibodies were used in the above example, it is to be understood that any affinity product can be used in place of the antibody as is known to those skilled in the art. Further it is possible to analyze more than one analyte/antigen by using more than one antibody or affinity product.
[0044] Although the analyte/antigen was found on the surface of the cell in the above exam-pie, it is to be understood that analytes/antigens can also be found within the cell and methods for the analysis of these internal analytes/antigens are included in this invention.
10045] Experiment 2 [0046] Yet another embodiment can be demonstrated by example of rhodium- containing (Rh(III)) metallointercalator binding to cells. Binding of an intercalator to DNA is governed by the law of mass action. Assuming that a mammalian cell in G1 phase has 3.3x109 DNA
base pairs of which only 10-70% are free from protein interaction (nucleosomes) and available for binding with the interca-lator (one molecule per two base pairs at saturation), the number of molecules of dye needed is ap-proximately 1-10x108. Thus for [Rh(phi)2bpy]C13 , with 671 MW, lml of 200uM
solution should be 100-fold excess of intercalator over DNA binding sites for 1x106 cells. The binding of various amounts of the Rh(III) intercalator with cultured cells was assessed. MBA-1 cells were fixed in 3.7% formalde-hyde/PBS for 15 minutes, followed by permeabilization with 0.3% TritonX-100/PBS; washed once with PBS and incubated for 45 minutes with lml of increasing concentrations of [Rh(phi)2bpy]C13 from 2.5 nanoM to 250 microM. Each sample contained 1x106 cells, run in triplicates.
Following washing, the cell pellets were treated with concentrated HC1, mixed with an equal volume of lppb Ir internal stan-dard, and analyzed in solution by ICP-MS. Figure 2 shows a linear normalized signal response. There-fore, it is observed that the intercalator can bind to DNA in a very broad range of concentrations without reaching a saturation limit.
[0047] Reactivity of the Rh(III) metallointercalator with fixed and fixed/permeabilized versus live cells was also examined. Equal amounts of MBA-1 cells (1x106) were either fixed/permeabilized as above, fixed in 3.7% formaldehyde alone or left untreated (live cells).
After two washes in PBS the cells were incubated with 200uM [Rh(phi)2bpy]C13 for 30 minutes; washed three more times and dis-solved in HC1. Figure 3 shows a representative graph of two experiments. As evident from Figure 3, in live cells the Rh(III) complex is membrane impermeable, while fixation and fixation/permeabilization permit DNA and metal complex intercalation to similar levels. Therefore, it is observed that non-specific binding of the intercalator to the cell surface is very limited; the complex is not internalized by live cells and the concentration of the Rh(III) complex corresponds to DNA
content. Exact ratio of the intercalator to DNA content was investigated in following experiments.
[0048] Experiment 3.
1 0 [0049] Yet another embodiment can be demonstrated by example of DNA labeling with Rh(III) metallointercalator and antigen CD33 surface labeling using solution and particle elemental analysis as shown in Figure 4 and Figure 9.
[0050] MBA-1 cells were fixed/permeabilized with 3.7% formaldehyde and 0.3% Triton X-100 and labeled with Rh(III) intercalator (250 microM). Triplicate samples with 3x104, 3x105, and 1 5 3x106 cells per tube were prepared. Cells were then incubated with the primary anti-CD33 antibody, followed by secondary Eu-labeled anti-mouse antibody. Cells were washed in 0.65 urn centrifugal spin filters (Durapore). After the final wash, filter units were placed over new eppendorf tubes and 80 mi-croL of concentrated HC1 were added. Overnight digestion of cellular material was followed by cen-trifugation and the filtrate was collected, combined with equal volume of Jr internal standard and sub-20 jected to ICP-MS. Figure 4 shows simultaneous identification of Rh (representing cell numbers) and Eu (representing cell surface antigen CD33) by solution elemental analysis.
[0051] Experiment 4.
[0052] In another embodiment, DNA bound to Rh(III) intercalator and surface antigen expres-sion were detected in single cells by particle elemental analysis with ICP-MS
operated in transient mode 25 (for flow chart see Figure 9). For these experiments, KG-la cells were treated with the Rh(III) interca-lator as described above. The CD34 surface antigen was detected via primary anti-CD34 antibody and secondary gold (Au) labeled anti-mouse antibody. A cell suspension of 1 xl0scells/m1 was prepared in 50 mM ammonium bicarbonate buffer, pH7.4. The suspension was aspirated into the ion source of Elan6100 ICP-MS at a rate of 40 microliters per minute, resulting in an average rate of 67 cells per sec-30 ond. Two sets of experiments were conducted: one with the mass analyzer set to m/z=103 for Rh+ de-tection, another - with rn/z=197 for Au + detection. The detector was operated in the transient mode, e.g.
the ion signals were detected from an output of the analog stage amplifier by storage oscilloscope (HP
54610B, Hewlett Packard), and the recorded signals were transferred to a computer for processing. Fig-ure 5 shows the examples of data collected for KG-la cells, with analyzer set to m/z=103 (Figure 5A) and to m/z=197 (Figure 5B). In Figure 5A, signals of Rh+ recorded for 16 Rh-positive Au-positive cells are compared to the averaged (n=4) signal for control Rh-negative Au-positive cells. Two kinds of tran-sients were observed: more frequently appearing relatively short higher amplitude (70 -110 microsecond full width at a half maximum) and less frequent long (> 150 microsecond) with some fine structure and lower amplitude. The total number of ions recalculated from the areas of the peaks (after accounting for detector and amplifier gains) is similar between short and long transients, averaging at 500 +-1 80 Rh+
ions per transient. The number of ions in the transient should scale with the number of intracellular Rh(III) labels, thus providing an evaluation of the cellular DNA and cell size. Experiments (not shown) with larger K562 cells (ca. 25 micrometer size compared to 10 micrometer for KG-1a) have shown that the transients contained on average 5600 Rh + ions. Detection of Au+ label from Rh-positive Au-positive KG-la cells is shown in Figure 5B. The signals are compared to the background of Au + signal meas-ured after the sample introduction system was rinsed and washed-out for 20 minutes with 2% HC1 (no Au + could be detected for the control Rh-positive Au-negative cells introduced before). The transient areas average at 72+-17 Au+ ions per peak.
1 5 100531 Experiment 5 [0054] Yet another embodiment can be demonstrated by example of the DNA content in dif-ferent cell cycle phases determined with metallointercalator (see flow chart of Figure 8). Cells were synchronized in G1 /S and G2/M phases of the cell cycle using a DNA synthesis inhibitor, thymidine, followed by a mitotic inhibitor, nocodazole. The DNA content of the GO/G1 phase is centered at 2n.
Treatment with double thymidine results in a Gl/S-phase arrested cell population with approximately 3n DNA content. Nocodazole addition following a single thymidine treatment arrests cells in the G2/M
stage with 4n DNA content. K562 cells were treated with 2mM thymidine added to culture medium for 17 hours. The cells were then washed and incubated in fresh media for 9 hours.
At the end of this rest period the culture was split into two flasks ¨ one received the second dose of 2mM thymidine (double thymidine block) to arrest cells at Gl/S; the other ¨ 0.2 ug/ml nocodazole (single thymidine-nocodazole block) to arrest cells at the M phase. The inhibitors were left in culture media for 17 hours. Finally, cells were collected, washed by centrifugation and prepared for DNA staining with propidium iodide (PI) or [Rh(phi)2bpy]C13. Cells for PI staining were fixed in 75% ethanol at -20 C for several hours and incubated with 10 microg/ml PI in 1.1% sodium citrate buffer with 1 mg/ml RNase according to stan-dard protocol. Flow cytometry was done on FACSCalibur (BD Biosciences) and the results confirmed that after the double thymidine block the majority of cells were in Gl/S, and after the M block practi-cally all cells were in M phase. For Rh(III) complex staining the cells were fixed in 3.7% formalde-hyde, washed and incubated in 100 uM [Rh(phi)2bpy]C13 solution. After several washes the cells were digested in concentrated HC1 and analyzed by ICP-MS. Figure 6 illustrates content of DNA (normalized response) depending on the cell cycle phase: mitotic (M), synthetic (Gl/S) or normal growth (UN).
Moreover, the binding of intercalating metal compound was influenced by 10 U/ml Proteinase K (P) or 1 mg/ml RNAse A (R) digestion of stained cells. As evident from the graph, unsynchronized cells have considerably less DNA than mitotic cells, which have approximately two-fold higher amounts of nucleic acid than Gl/S phase cells. Treatment of stained cells with enzymes shifts the detected Rh values due to enhanced binding of metallointercalator to naked DNA. As seen in Figure 6, the amount of Rh is higher in enzyme treated samples R and P for cells in the Gl/S phase and unsynchronized cultures (UN) com-pared to nontreated control cultures (non). This may be the result of protease degradation of DNA bind-ing proteins and hence more nucleic acid being exposed to binding with the metallointercalator for P
samples. In the case of RNAse A treatment ¨ degradation of small RNA molecules bound to DNA such as siRNA that may block interaction of intercalator and DNA may lead to higher detected Rh values.
On the other hand, during mitosis, when DNA is tightly packed into nucleosomes within the mitotic chromosomes enzymes fail to uncover "naked DNA" and this results in lower Rh signals.
[0055] Although ICP-MS was used in the above examples, it is to be understood that other forms of elemental analysis are encompassed in the applicant's teachings.
[0056] Kits.
[0057] Also provided are kits comprising the components for the analysis by elemental mass spectrometry for the methods described above.
[0058] For example, a kit is provided for the method of example 1 for the detection and meas-urement of elements, for example rare earth or transition elements in a sample, where the measured ele-ments originated from an element passively accumulated by cells. The kit can comprise a soluble corn-pound of the element for addition to a cell growth media. The kit may further comprise instructions for i) spiking a cell growth media with the soluble compound of an element, ii) separating bound material from unbound material, and iii) detecting and measuring the passively accumulated element by elemen-tal analysis.
[0059] A kit is also provided for the detection and measurement of an element, for example a rare earth or transition element, in a sample, where the measured elements originated from an element tag on an analyte specific affinity product that binds with at least one of intra- and/or extra-cellular ana-lyte or analyte complex as described in example 1. The kit can comprise an element tag comprising the element for directly tagging an analyte specific antibody. The kit can further comprise instructions for (i) directly tagging an analyte specific affinity product; (ii) combining the tagged analyte specific affin-ity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra-or/and extra-cellular analyte and analyte complex, (iii) separating bound material from unbound material, and iv) detecting and measur-ing the element tag by elemental analysis.
[0060] Also provided is a kit comprising the combination of the components of the kits de-scribed above for the passive accumulation of elements by a cell and for an affinity product labeled with an element, wherein the affinity product is specific to an analyte in a cell or on the cell surface.
The kit may further comprise an analyte specific affinity product, wherein the analyte specific affinity product is directly tagged with an element tag.
[0061] Also provided is a kit for the detection and measurement of an element, for example a rare earth or transition element in a sample, where the measured elements originated from a metal con-taining DNA intercalator for the method described in example 2. The kit can comprise a metal contain-ing intercalator, and optionally instructions for i) conditions appropriate to incorporate the element containing intercalator into the DNA within the cells of the sample, ii) separating bound material from unbound material, and iii) detecting and measuring the element containing intercalator by elemental analysis. Also provided is a combination kit comprising these components and the components for the kit for the method of detecting an analyte in or on a cell using a element labeled affinity product. Fur-ther, the kit can comprise an analyte specific affinity product, wherein the analyte specific affinity product is directly tagged with an element tag.
[0062] For any of the kits described above, the element can be measured using an ICP-mass spectrometer. The element can be an isotope or ion. The element can be selected from a group consist-ing of the transitions elements, noble metals, lanthanides, rare earth elements, gold, silver, platinum, rhodium, iridium and palladium. The affinity product can be selected from the group consisting of Fab', aptamer, antigen, hormone, growth factor, receptor, protein, SH2 peptides and nucleic acid. The element can include more than one atom of an isotope. The element can include a different number of atoms of each isotope.
[0063] Any of the kits can further comprise standards, a dilution buffer, an elution buffer, a wash buffer, and/or an assay buffer. Further, the kits can comprise two or more elemental tags for sim-ultaneous determination of two or more analytes. The analyte can be a cytokine. A skilled worker, hay-ing read the specification, would understand how these components work in the methods of the present invention.
[0064] The kits described above can further comprise instructions for elemental mass analysis by mass spectrometry.
[0065] While the applicant's teachings are described in conjunction with various embodiments, it is not intended that the applicant's teachings be limited to such embodiments. On the contrary, the applicant's teachings encompass various alternatives, modifications, and equivalents, as will be appre-ciated by those of skill in the art.
Reference List 1. Long, E. C.; Barton, J. K. On Demonstrating Dna Intercalation Accounts of Chemical Research 1990, 23, 271-73.
2. Barton, J. K. Targeting Dna Sites with Chiral Metal-Complexes Pure and Applied Chemisny 1989, 61, 563-64.
3. Chow, C. S.; Barton, J. K. Transition-Metal Complexes As Probes of Nucleic-Acids Methods in Enzymology 1992, 212, 219-42.
4. Labarca, C.; Paigen, K. A simple, rapid, and sensitive DNA assay procedure Anal.Biochem.
1980, 102, 344-52.
5. Plander, M.; Brockhoff, G.; Barlage, S.; Schwarz, S.; Rothe, G.;
Knuechel, R. Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens Cytometty Part A 2003, 54A, 66-74.
6. Paulsson, K.; Fioretos, T.; Strombeck, B.; Mauritzson, N.; Tanke, H. J.;
Johansson, B. Trisomy 1 5 8 as the sole chromosomal aberration in myelocytic malignancies: a multicolor and locus-specific fluo-rescence in situ hybridization study Cancer Genetics and Cytogenetics 2003, 140, 66-69.
7. Gong, J.; Li, X.; Traganos, F.; Darzynkiewicz, Z. Expression of G(1) and G(2) Cyclins Meas-ured in Individual Cells by Multiparameter Flow-Cytometry - A New Tool in the Analysis of the Cell-Cycle Cell Proliferation 1994, 27, 357-71.
8. Nowak, R.; Oelschlaegel, U.; Schuler, U.; Zengler, H.; Hofmann, R.;
Ehninger, G.; Andreeff, M. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow Cytometry 1997, 30, 47-53.
9. Latt, S. A.; Stetten, G. Spectral Studies on 33258-Hoechst and Related Bisbenzimidazole Dyes Useful for Fluorescent Detection of Deoxyribonucleic-Acid Synthesis Journal of Histochemistry & Cy-tochemistry 1976, 24, 24-33.
[00101 A "transition element" means any element having the following atomic numbers, 21-29, 39-47, 57-79, and 89. Transition elements include the rare earth elements, lanthanides, and noble metals (Cotton and Wilkinson, 1972).
[0011] An "internal standard" is defined as a known amount of a compound, different from analyte, that is added to the unknown. Signal from analyte is compared with signal from the internal standard to find out how much analyte is present. An internal standard normally is used when perform-ing mass spectrometry quantitation. An internal standard can also be used by other means known to those skilled in the art.
[0012] Fixing and permeabilization refers to chemical cross-linking of cellular components by agents known to those skilled in the art, and may include but not limited to glutaraldehyde, formalde-hyde, formalin, ethanol, methanol, etc., and creating holes in the cell membrane with detergents. Suit-able detergents may be readily selected from among non-ionic detergents. These detergents may be used at a concentration between about 0.001% to about 0.1%. One currently preferred detergent is Tri-tonTs4 X-100 (Sigma T9284). Examples of other suitable detergents include Igepal0 and Nonidet P-40. Other suitable detergents may be readily selected by one of skill in the art.
[0013] It is accepted in cell biology that the content of nucleic acids is a reasonable indicator of cell number owing to the tight regulation of DNA and RNA levels in the cells.
DNA measurement is commonly used to estimate the number of cells in solid tumors as well as to characterize hematopoiet-ic malignancies and monitor chemotherapy treatmene's. Many studies demonstrate the prognostic sig-nificance of ploidy in human tumors. For example, trisomy 8 is one of the most frequent numerical chromosomal abnormalities observed in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)6. The content of DNA also reflects cell cycle progression.
Cells grow through mito-sis and the individual cells can be identified or classified, through their progression by mitosis, with a determination of the amount of DNA in the cell. In combination with antigen identification, the meas-urement of DNA indicates the ploidy or cell cycle phase for a subset of cells defined by the antigen in heterogeneous cell populations, or the distribution of a particular antigen through the cell cycle's.
[0014] Reagents that measure cell proliferation and cell numbers are important diagnostic and research tools. Standard methods of cell enumeration include BrdU (5-bromo-2'-deoxyuridine); 3H-thymidine incorporation into replicating cells during proliferation, and the measurement of total nucle-ic acid content of lysed cells with a calorimetric (diphenylamine) reagent.
Fluorescent DNA intercalat-ing dyes in conjunction with flow cytometry have become the method of choice for rapid cell cycle and cell number measurements. Such DNA binding dyes as Hoechst 332589, propidium iodide , DAPIII and acridine orange" have been shown in many applications to accurately estimate cell num-bers. However, these reagents suffer from relatively low fluorescence enhancements upon binding nu-cleic acids, low extinction coefficients and have high intrinsic background fluorescence. Recently, a novel class of cyanine dyes and a sensitive nucleic acid stain-based assay have been developed by Mo-lecular Probes Inc. which obviates these problems".
[0015] Metallointercalators interact with double-stranded DNA through electrostatic forces--groove binding and intercalation, for example. Substantial research has been devoted to the photolumines-Cent14-16 and photo-oxidizing properties of metallointercalators17-21. 9,10-Phenanthrenequinone diimine (phi) complexes of rhodium(III) (Rh(III)) have been shown to bind tightly (Kd 40-8M) to double stranded DNA by intercalation in the major groove22-24 and undergo a variety of photoinduced reac-tions with DNA20'23-23. From photofootprinting experiments Barton et al.
(1992) concluded that Rh(phi)2(bpy)3+ has a rigid rhodium complex that can occupy directly all sites not obstructed by DNA
binding proteins, and at rhodium/base pair ratios of 2:1 binding to DNA is sequence neutral and ran-dom28'29. Recent work from the same group has also shown that metallointercalators which targeted major groove sites bind poorly to double-stranded RNA3631. However, other experiments indicate that the apposition of several non-canonical bases as well as stem-loop junctions and bulges in tRNA could result in intimately stacked structures with opened major grooves accessible for metallointercalator [0016] Recently, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) has been intro-duced to the field of protein and cell surface antigen identification via ICP-MS-linked immunoassays using metal containing immunoreagents such as gold and lanthanide-conjugated antibodies32-35. ICP-1 0 MS as an analytical detector offers absolute quantification that is largely independent of the analyte mo-lecular form or sample matrix. Secondly, the abundance sensitivity of ICP-MS, a measure of the over-lap of signals of neighboring isotopes, is large (>106 for the quadrupole analyzer), and this ensures inde-pendence of the detection channels over a wide dynamic range. The third key property is that ICP-MS
is very sensitive; it was demonstrated that ICP-MS-linked immunoassays can be at least as sensitive as radioimrnunoassay.
[0017] ICP-MS is extensively used to study natural and induced metal incorporation into bacte-ria36-39, plants4 and as a tool in metalloproteomics research'''.
[0018] The choice of the element to be employed in the methods of the present invention is preferably selected on the basis of its natural abundance in the sample under investigation and whether the element is cytotoxic to the sample under investigation.
[0019] Most metals of the transition and rare earth groups are anticipated for use in passive uptake labeling of cultured cells. It is wise to choose elements that have low or no cytotoxicity and have a low abundance in growth media and biological samples. For example, vanadium and mercury can be toxic to certain cells, while Fe, Cu and Zn can be present in high concentrations in some cell culture media. On the other hand, Pr, Ho, Tb, La, for example are normally well tolerated by mammalian cells and are not abundant in the environment.
[0020] Metallointercalators are synthesized using aromatic compounds as ligands for DNA
binding and transition-metal complex cores. Metallointercalators can incorporate many types of metal centers such as Ru, Rh, Os, Co, Re, and Jr. A vast number of ligands are known to those skilled in the art (bipyridine, 9,10-phenanthrene quinone diimine, 1,10-phenanthroline, etc).
Other element labeled DNA intercalators can also be used.
[0021] An unusual isotope composition of the tag element can be used in order to distinguish between naturally present elements in the sample and the tag material. It is advantageous if the relative abundance of the tag elements is sufficiently different from the relative abundance of elements in a given sample under analysis. By "sufficiently different" it is meant that under the methods of the pre-sent invention it is possible to detect the target elemental tag over the background elements contained in a sample under analysis. Indeed, it is the difference in inter-elemental ratios of the tagging elements and the sample matrix that can be used advantageously to analyze the sample.
[0022] It is feasible to select elemental tags, which do not produce interfering signals during analysis (i.e. do not have over-lapping signals due to having the same mass).
Therefore, two or more analytical determinations can be performed simultaneously in one sample.
Moreover, because the ele-mental tag can be made containing many copies of the same atoms, the measured signal can be greatly amplified.
SUMMARY
[0023] These and other features of the applicant's teachings are set forth herein. An aspect of the applicant's teachings is to provide a method to quantify the number of cells in a sample comprising cells, the method comprising: culturing the sample with an element to passively accumulate the element in the cells in the sample; washing the cells to remove non-accumulated element; measuring the element 1 5 in a known quantity of the cells by elemental analysis to determine the amount of accumulated element per cell; measuring the element in the sample by elemental analysis; and quantifying the number of cells in the sample.
[0024] Another aspect of the applicant's teachings is to provide a method to quantify antigen content per cell in a cell sample wherein the cells of the sample comprise an antigen, comprising: cultur-ing the cells of the sample in the presence of a first element wherein the cells passively accumulate the first element; calculating the number of cells in the sample; removing non-accumulated first element;
incubating the cells with antigen specific affinity products labeled with a second element tag; removing unbound affinity products; simultaneously measuring the passively accumulated first element and the amount of the bound affinity product labeled with a second element tag by elemental analysis; and cal-culating the antigen content per cell.
[0025] Another aspect of the applicant's teachings is to provide a method for determining the phase of a cell cycle in a sample of cells, comprising: determining the number of cells in the sample;
fixing and permeabilizing the cells; exposing the sample of cells to an element containing intercalator under conditions appropriate to incorporate the intercalator into the DNA
within the cells of the sample.
removing unbound intercalator; measuring the content of the labeled DNA within the cells by elemental analysis of the element; determining the amount of DNA per cell; and determining the phase of the cell cycle from the amount of DNA per cell.
[0026] Another aspect of the applicant's teachings is to provide a method to determine DNA
content and antigen content per cell in a sample of cells, comprising:
determining the number of cells in the sample; fixing and permeabilizing the cells; incubating the sample of cells with an intercalator tagged with a first element under conditions appropriate to incorporate the intercalator into the DNA
within the cells of the sample; removing unbound intercalator from the cells;
incubating antigen specific affinity products labeled with a second element tag with the cells; removing unbound affinity products from the cells; simultaneously measuring the intercalator and the affinity product labeled with the sec-ond element tag by elemental analysis; and calculating the DNA content and antigen content per cell.
[0027] Another aspect of the applicant's teachings is to provide a kit for the detection and measurement of a first element in a sample, where the measured first element originated from the first element passively accumulated by cells, comprising: (a) a soluble compound of a first element for addi-1 0 tion to a cell media. The kit can further comprise instructions for (i) spiking a cell media with the solu-ble compound of the first element, ii) separating bound first element from unbound first element, and iii) detecting and measuring the passively accumulated first element by elemental analysis. The kit can fur-ther comprise (a) a second element for directly tagging an analyte specific affinity product; and (b) an analyte specific affinity product. The kit can further comprise instructions for (i) directly tagging the 1 5 analyte specific affinity product with the second element; (ii) combining the tagged analyte specific af-finity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra-or/and extra-cellular analyte and analyte complex, (iii) separating bound affinity product from unbound affinity product, and iv) detecting and measuring the second element by elemental analysis. The kit can further comprise an analyte spe-20 cific affinity product, wherein the analyte specific affinity product is directly tagged with a second ele-ment.
[00281 Another aspect of the applicant's teachings is to provide a kit for the detection and measurement of a first element in a sample, where the measured first element originated from a DNA
intercalator, comprising: (a) a DNA intercalator comprising a first element.
The kit can further compris-2 5 ing instructions for i) incorporating the first element containing intercalator into the DNA within the cells of the sample, ii) separating bound intercalator from unbound intercalator, and iii) detecting and measuring the intercalator comprising the first element by elemental analysis.
The kit can further com-prise (a) a second element for directly tagging an analyte specific affinity product; and (b) an analyte specific affinity product. The kit can further comprise instructions for (i) directly tagging an analyte 30 specific affinity product; (ii) combining the tagged analyte specific affinity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra- or/and extra-cellular analyte and analyte complex, (iii) separat-ing bound affinity product from unbound affinity product, and iv) detecting and measuring the second element by elemental analysis. The kit can further comprise an analyte specific affinity product wherein 35 the analyte specific affinity product is directly tagged with a second element.
BRIEF DESCRIPTION OF THE FIGURES
[0029] Figure 1A. Upper plot - linear response between number of KG-la cells present in each sample and amount of CD34 antigen detected as signal from Eu normalized to Ir internal standard (Eu/Ir) with background subtracted. Lower plot ¨ relationship of KG-la cell numbers and accumulated metal, palladium, normalized to Jr internal standard (Pd/1r).
[0030] Figure 1B. Upper bar graph ¨ mixed cell samples ( lo,2o,3o,4o,5o,7o on the Y ¨axis) were incubated with negative control isotype specific immunoglobulin and Eu-labeled secondary anti-bodies; analyzed for Eu, Pd, and Rh; signal values are relative to Jr internal standard. Lower bar graph ¨
samples (#1, #2, #3, #4, #5, #7 on the Y-axis) were incubated with anti-CD34 primary and Eu-labeled secondary antibodies; analyzed for Eu, Pd, and Rh; signal values are relative to Jr internal standard.
[0031] Figure 2. Linear concentration dependence between amounts of Rh(III) metalointercala-tor and signal obtained from treated cells (normalized response).
[0032] Figure 3. Normalized response for Rh obtained after treating live, or fixed, or fixed/permeabilized (fix/perm) MBA-1 cells with Rh(III) complex.
1 5 [0033] Figure 4. Simultaneous identification of cellular DNA
(Rh) and surface antigen CD33 (Eu) by solution elemental analysis. MBA-1 cells were treated with Rh(III) complex and reacted with anti-CD33 antibodies followed by Eu-labeled secondary antibodies. Sample #1 contains 3x104, sample #2 - 3x105, and sample #3 - 3x106 cells.
[0034] Figure 5. Detection of the internal Rh(III) labels (A) and the surface Au labels (B) by particle elemental analysis with ICP-MS operated in transient mode. Single cell analysis of surface an-tigen CD34 expression (Au) and intracellular DNA (Rh) content were analyzed.
KG-la cells were treated with intercalator and reacted with anti-CD34 antibodies followed by Au-labeled secondary anti-bodies.
[0035] Figure 6. DNA content (Rh, normalized response) depending on cell cycle phase. K562 cells were grown under normal conditions (UN) or treated for synchronization in the mitotic (M) or syn-thetic (Gl/S) phase. Fixed cells were stained with Rh(III) complex and analyzed non-treated (non) or digested in Proteinase K (P) or RNAse A (R) solutions.
[0036] Figure 7. Chart showing a method to quantify antigen content per cell, in accordance with the invention.
[0037] Figure 8. Chart showing a method for determination of cell cycle phase, in accordance with the invention.
[0038] Figure 9. Chart showing a method to determine DNA and antigen content per cell, in accordance with the invention.
DESCRIPTION OF THE VARIOUS EMBODIMENTS
[0039] Aspects of the applicant's teachings may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teachings in any way.
[0040] Experiment I.
[0041] One embodiment can be demonstrated by example of rhodium (Rh) and palladium (Pd) in mixed cell populations with surface marker identified by europium (Eu). The experiment was set up to investigate if metals passively accumulated by cells could be indicative of cell number and cell type.
A work flow chart is presented in Figure 7. For this purpose two different leukemia cell lines were cul-tured for 72 hours in growth media supplemented with very low amounts of rare earth metals: 100ppb Rh was added to MBA-1 cells, and 500 ppb Pd was added to KG-la cells which express the cell surface marker. During the three days of cell culture, aliquots of cells were tested for viability with trypan blue.
1 5 No excessive cell death was recorded due to the presence of metals in media. Cells were collected by centrifugation (1200 rpm, 10 minutes), washed once in PBS/10%FBS and counted in a hemocytometer.
Serial dilutions were prepared to give 1 x106, 0.5 x106, 1 x105, 1 x104, 1 x103, and 1 x102 KG-la cells in a population of MBA-1 cells (1x106) per tube in triplicates (Tablel). In this example Pd will reflect the number of KG-la cells and the presence of surface marker CD34 will specify the cell type, while MBA-1 cells are marked by Rh. Immunolabeling was carried out by adding anti-CD34 antibodies to tubes containing decreasing amounts of live KG-la cells and incubating for 45 minutes on ice. Negative con-trol tubes were reacted with the IgG1 isotype control immunoglobulins. After three low speed centrifu-gation washes with PBS/10%FBS all samples were incubated with biotinylated anti-mouse antibodies.
This was followed by several washes, and Eu-labeled streptavidin (DELFIA, Perkin Elmer) was added to all samples as the last step in the immunolabeling procedure. Unreacted Eu-strepavidin was elimi-nated by three final washes. Cell pellets were then dissolved overnight in 75u1 of concentrated HC1.
Prior to ICP-MS analysis, an equal volume of lppb iridium standard (Ir) was added to each sample.
Three independent experiments were performed. ICP-MS acquisition of Eu, Rh and Pd signals are pre-sented in Figure 1A and Figure 1B. In this example, the detection limit for an abundant biomarker (CD34) is ¨1000 cells in the presence of 1x106 unrelated cells. Therefore, passive metal accumulation by cells can be used for normalization of a biomarker concentration in solution and particle elemental analysis.
[0042] Table 1. Samples containing mixed populations of cells cultured in media supplemented with palladium (Pd) or rhodium (Rh).
Sample KG1-a (Pd) MBA-1 (Rh) #1, lo 1e6 0 #2,2o 5e5 5e5 #3,3o 1e5 1e6 #4,4o 1e4 1e6 #5,5o 1e3 1e6 #7,7o 0 1e6 [0043] Although antibodies were used in the above example, it is to be understood that any affinity product can be used in place of the antibody as is known to those skilled in the art. Further it is possible to analyze more than one analyte/antigen by using more than one antibody or affinity product.
[0044] Although the analyte/antigen was found on the surface of the cell in the above exam-pie, it is to be understood that analytes/antigens can also be found within the cell and methods for the analysis of these internal analytes/antigens are included in this invention.
10045] Experiment 2 [0046] Yet another embodiment can be demonstrated by example of rhodium- containing (Rh(III)) metallointercalator binding to cells. Binding of an intercalator to DNA is governed by the law of mass action. Assuming that a mammalian cell in G1 phase has 3.3x109 DNA
base pairs of which only 10-70% are free from protein interaction (nucleosomes) and available for binding with the interca-lator (one molecule per two base pairs at saturation), the number of molecules of dye needed is ap-proximately 1-10x108. Thus for [Rh(phi)2bpy]C13 , with 671 MW, lml of 200uM
solution should be 100-fold excess of intercalator over DNA binding sites for 1x106 cells. The binding of various amounts of the Rh(III) intercalator with cultured cells was assessed. MBA-1 cells were fixed in 3.7% formalde-hyde/PBS for 15 minutes, followed by permeabilization with 0.3% TritonX-100/PBS; washed once with PBS and incubated for 45 minutes with lml of increasing concentrations of [Rh(phi)2bpy]C13 from 2.5 nanoM to 250 microM. Each sample contained 1x106 cells, run in triplicates.
Following washing, the cell pellets were treated with concentrated HC1, mixed with an equal volume of lppb Ir internal stan-dard, and analyzed in solution by ICP-MS. Figure 2 shows a linear normalized signal response. There-fore, it is observed that the intercalator can bind to DNA in a very broad range of concentrations without reaching a saturation limit.
[0047] Reactivity of the Rh(III) metallointercalator with fixed and fixed/permeabilized versus live cells was also examined. Equal amounts of MBA-1 cells (1x106) were either fixed/permeabilized as above, fixed in 3.7% formaldehyde alone or left untreated (live cells).
After two washes in PBS the cells were incubated with 200uM [Rh(phi)2bpy]C13 for 30 minutes; washed three more times and dis-solved in HC1. Figure 3 shows a representative graph of two experiments. As evident from Figure 3, in live cells the Rh(III) complex is membrane impermeable, while fixation and fixation/permeabilization permit DNA and metal complex intercalation to similar levels. Therefore, it is observed that non-specific binding of the intercalator to the cell surface is very limited; the complex is not internalized by live cells and the concentration of the Rh(III) complex corresponds to DNA
content. Exact ratio of the intercalator to DNA content was investigated in following experiments.
[0048] Experiment 3.
1 0 [0049] Yet another embodiment can be demonstrated by example of DNA labeling with Rh(III) metallointercalator and antigen CD33 surface labeling using solution and particle elemental analysis as shown in Figure 4 and Figure 9.
[0050] MBA-1 cells were fixed/permeabilized with 3.7% formaldehyde and 0.3% Triton X-100 and labeled with Rh(III) intercalator (250 microM). Triplicate samples with 3x104, 3x105, and 1 5 3x106 cells per tube were prepared. Cells were then incubated with the primary anti-CD33 antibody, followed by secondary Eu-labeled anti-mouse antibody. Cells were washed in 0.65 urn centrifugal spin filters (Durapore). After the final wash, filter units were placed over new eppendorf tubes and 80 mi-croL of concentrated HC1 were added. Overnight digestion of cellular material was followed by cen-trifugation and the filtrate was collected, combined with equal volume of Jr internal standard and sub-20 jected to ICP-MS. Figure 4 shows simultaneous identification of Rh (representing cell numbers) and Eu (representing cell surface antigen CD33) by solution elemental analysis.
[0051] Experiment 4.
[0052] In another embodiment, DNA bound to Rh(III) intercalator and surface antigen expres-sion were detected in single cells by particle elemental analysis with ICP-MS
operated in transient mode 25 (for flow chart see Figure 9). For these experiments, KG-la cells were treated with the Rh(III) interca-lator as described above. The CD34 surface antigen was detected via primary anti-CD34 antibody and secondary gold (Au) labeled anti-mouse antibody. A cell suspension of 1 xl0scells/m1 was prepared in 50 mM ammonium bicarbonate buffer, pH7.4. The suspension was aspirated into the ion source of Elan6100 ICP-MS at a rate of 40 microliters per minute, resulting in an average rate of 67 cells per sec-30 ond. Two sets of experiments were conducted: one with the mass analyzer set to m/z=103 for Rh+ de-tection, another - with rn/z=197 for Au + detection. The detector was operated in the transient mode, e.g.
the ion signals were detected from an output of the analog stage amplifier by storage oscilloscope (HP
54610B, Hewlett Packard), and the recorded signals were transferred to a computer for processing. Fig-ure 5 shows the examples of data collected for KG-la cells, with analyzer set to m/z=103 (Figure 5A) and to m/z=197 (Figure 5B). In Figure 5A, signals of Rh+ recorded for 16 Rh-positive Au-positive cells are compared to the averaged (n=4) signal for control Rh-negative Au-positive cells. Two kinds of tran-sients were observed: more frequently appearing relatively short higher amplitude (70 -110 microsecond full width at a half maximum) and less frequent long (> 150 microsecond) with some fine structure and lower amplitude. The total number of ions recalculated from the areas of the peaks (after accounting for detector and amplifier gains) is similar between short and long transients, averaging at 500 +-1 80 Rh+
ions per transient. The number of ions in the transient should scale with the number of intracellular Rh(III) labels, thus providing an evaluation of the cellular DNA and cell size. Experiments (not shown) with larger K562 cells (ca. 25 micrometer size compared to 10 micrometer for KG-1a) have shown that the transients contained on average 5600 Rh + ions. Detection of Au+ label from Rh-positive Au-positive KG-la cells is shown in Figure 5B. The signals are compared to the background of Au + signal meas-ured after the sample introduction system was rinsed and washed-out for 20 minutes with 2% HC1 (no Au + could be detected for the control Rh-positive Au-negative cells introduced before). The transient areas average at 72+-17 Au+ ions per peak.
1 5 100531 Experiment 5 [0054] Yet another embodiment can be demonstrated by example of the DNA content in dif-ferent cell cycle phases determined with metallointercalator (see flow chart of Figure 8). Cells were synchronized in G1 /S and G2/M phases of the cell cycle using a DNA synthesis inhibitor, thymidine, followed by a mitotic inhibitor, nocodazole. The DNA content of the GO/G1 phase is centered at 2n.
Treatment with double thymidine results in a Gl/S-phase arrested cell population with approximately 3n DNA content. Nocodazole addition following a single thymidine treatment arrests cells in the G2/M
stage with 4n DNA content. K562 cells were treated with 2mM thymidine added to culture medium for 17 hours. The cells were then washed and incubated in fresh media for 9 hours.
At the end of this rest period the culture was split into two flasks ¨ one received the second dose of 2mM thymidine (double thymidine block) to arrest cells at Gl/S; the other ¨ 0.2 ug/ml nocodazole (single thymidine-nocodazole block) to arrest cells at the M phase. The inhibitors were left in culture media for 17 hours. Finally, cells were collected, washed by centrifugation and prepared for DNA staining with propidium iodide (PI) or [Rh(phi)2bpy]C13. Cells for PI staining were fixed in 75% ethanol at -20 C for several hours and incubated with 10 microg/ml PI in 1.1% sodium citrate buffer with 1 mg/ml RNase according to stan-dard protocol. Flow cytometry was done on FACSCalibur (BD Biosciences) and the results confirmed that after the double thymidine block the majority of cells were in Gl/S, and after the M block practi-cally all cells were in M phase. For Rh(III) complex staining the cells were fixed in 3.7% formalde-hyde, washed and incubated in 100 uM [Rh(phi)2bpy]C13 solution. After several washes the cells were digested in concentrated HC1 and analyzed by ICP-MS. Figure 6 illustrates content of DNA (normalized response) depending on the cell cycle phase: mitotic (M), synthetic (Gl/S) or normal growth (UN).
Moreover, the binding of intercalating metal compound was influenced by 10 U/ml Proteinase K (P) or 1 mg/ml RNAse A (R) digestion of stained cells. As evident from the graph, unsynchronized cells have considerably less DNA than mitotic cells, which have approximately two-fold higher amounts of nucleic acid than Gl/S phase cells. Treatment of stained cells with enzymes shifts the detected Rh values due to enhanced binding of metallointercalator to naked DNA. As seen in Figure 6, the amount of Rh is higher in enzyme treated samples R and P for cells in the Gl/S phase and unsynchronized cultures (UN) com-pared to nontreated control cultures (non). This may be the result of protease degradation of DNA bind-ing proteins and hence more nucleic acid being exposed to binding with the metallointercalator for P
samples. In the case of RNAse A treatment ¨ degradation of small RNA molecules bound to DNA such as siRNA that may block interaction of intercalator and DNA may lead to higher detected Rh values.
On the other hand, during mitosis, when DNA is tightly packed into nucleosomes within the mitotic chromosomes enzymes fail to uncover "naked DNA" and this results in lower Rh signals.
[0055] Although ICP-MS was used in the above examples, it is to be understood that other forms of elemental analysis are encompassed in the applicant's teachings.
[0056] Kits.
[0057] Also provided are kits comprising the components for the analysis by elemental mass spectrometry for the methods described above.
[0058] For example, a kit is provided for the method of example 1 for the detection and meas-urement of elements, for example rare earth or transition elements in a sample, where the measured ele-ments originated from an element passively accumulated by cells. The kit can comprise a soluble corn-pound of the element for addition to a cell growth media. The kit may further comprise instructions for i) spiking a cell growth media with the soluble compound of an element, ii) separating bound material from unbound material, and iii) detecting and measuring the passively accumulated element by elemen-tal analysis.
[0059] A kit is also provided for the detection and measurement of an element, for example a rare earth or transition element, in a sample, where the measured elements originated from an element tag on an analyte specific affinity product that binds with at least one of intra- and/or extra-cellular ana-lyte or analyte complex as described in example 1. The kit can comprise an element tag comprising the element for directly tagging an analyte specific antibody. The kit can further comprise instructions for (i) directly tagging an analyte specific affinity product; (ii) combining the tagged analyte specific affin-ity product with at least one type of an analyte and analyte complex under conditions in which the tagged analyte specific affinity product binds with at least one of intra-or/and extra-cellular analyte and analyte complex, (iii) separating bound material from unbound material, and iv) detecting and measur-ing the element tag by elemental analysis.
[0060] Also provided is a kit comprising the combination of the components of the kits de-scribed above for the passive accumulation of elements by a cell and for an affinity product labeled with an element, wherein the affinity product is specific to an analyte in a cell or on the cell surface.
The kit may further comprise an analyte specific affinity product, wherein the analyte specific affinity product is directly tagged with an element tag.
[0061] Also provided is a kit for the detection and measurement of an element, for example a rare earth or transition element in a sample, where the measured elements originated from a metal con-taining DNA intercalator for the method described in example 2. The kit can comprise a metal contain-ing intercalator, and optionally instructions for i) conditions appropriate to incorporate the element containing intercalator into the DNA within the cells of the sample, ii) separating bound material from unbound material, and iii) detecting and measuring the element containing intercalator by elemental analysis. Also provided is a combination kit comprising these components and the components for the kit for the method of detecting an analyte in or on a cell using a element labeled affinity product. Fur-ther, the kit can comprise an analyte specific affinity product, wherein the analyte specific affinity product is directly tagged with an element tag.
[0062] For any of the kits described above, the element can be measured using an ICP-mass spectrometer. The element can be an isotope or ion. The element can be selected from a group consist-ing of the transitions elements, noble metals, lanthanides, rare earth elements, gold, silver, platinum, rhodium, iridium and palladium. The affinity product can be selected from the group consisting of Fab', aptamer, antigen, hormone, growth factor, receptor, protein, SH2 peptides and nucleic acid. The element can include more than one atom of an isotope. The element can include a different number of atoms of each isotope.
[0063] Any of the kits can further comprise standards, a dilution buffer, an elution buffer, a wash buffer, and/or an assay buffer. Further, the kits can comprise two or more elemental tags for sim-ultaneous determination of two or more analytes. The analyte can be a cytokine. A skilled worker, hay-ing read the specification, would understand how these components work in the methods of the present invention.
[0064] The kits described above can further comprise instructions for elemental mass analysis by mass spectrometry.
[0065] While the applicant's teachings are described in conjunction with various embodiments, it is not intended that the applicant's teachings be limited to such embodiments. On the contrary, the applicant's teachings encompass various alternatives, modifications, and equivalents, as will be appre-ciated by those of skill in the art.
Reference List 1. Long, E. C.; Barton, J. K. On Demonstrating Dna Intercalation Accounts of Chemical Research 1990, 23, 271-73.
2. Barton, J. K. Targeting Dna Sites with Chiral Metal-Complexes Pure and Applied Chemisny 1989, 61, 563-64.
3. Chow, C. S.; Barton, J. K. Transition-Metal Complexes As Probes of Nucleic-Acids Methods in Enzymology 1992, 212, 219-42.
4. Labarca, C.; Paigen, K. A simple, rapid, and sensitive DNA assay procedure Anal.Biochem.
1980, 102, 344-52.
5. Plander, M.; Brockhoff, G.; Barlage, S.; Schwarz, S.; Rothe, G.;
Knuechel, R. Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens Cytometty Part A 2003, 54A, 66-74.
6. Paulsson, K.; Fioretos, T.; Strombeck, B.; Mauritzson, N.; Tanke, H. J.;
Johansson, B. Trisomy 1 5 8 as the sole chromosomal aberration in myelocytic malignancies: a multicolor and locus-specific fluo-rescence in situ hybridization study Cancer Genetics and Cytogenetics 2003, 140, 66-69.
7. Gong, J.; Li, X.; Traganos, F.; Darzynkiewicz, Z. Expression of G(1) and G(2) Cyclins Meas-ured in Individual Cells by Multiparameter Flow-Cytometry - A New Tool in the Analysis of the Cell-Cycle Cell Proliferation 1994, 27, 357-71.
8. Nowak, R.; Oelschlaegel, U.; Schuler, U.; Zengler, H.; Hofmann, R.;
Ehninger, G.; Andreeff, M. Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow Cytometry 1997, 30, 47-53.
9. Latt, S. A.; Stetten, G. Spectral Studies on 33258-Hoechst and Related Bisbenzimidazole Dyes Useful for Fluorescent Detection of Deoxyribonucleic-Acid Synthesis Journal of Histochemistry & Cy-tochemistry 1976, 24, 24-33.
10. Krishan, A. Rapid DNA content analysis by the propidium iodide-hypotonic citrate method Methods Cell Biol. 1990, 33, 121-25.
11. Kapuscinski, J.; Skoczylas, B. Fluorescent Complexes of Dna with Dapi 4',6-Diamidine-2-Phenyl Indole.2Hcl Or Dci 4',6-Dicarboxyamide-2-Phenyl Indole Nucleic Acids Research 1978, 5, 3775-99.
12. BORISOVA, 0. F.; TUMERMAN, L. A.[LUMINESCENCE OF ACRIDINE ORANGE AND
NUCLEIC ACID COMPLEXES.] Biofizika 1964, 130, 537-44.
NUCLEIC ACID COMPLEXES.] Biofizika 1964, 130, 537-44.
13. Jones, L. J.; Gray, M.; Yue, S. T.; Haugland, R. P.; Singer, V. L.
Sensitive determination of cell number using the CyQUANT (R) cell proliferation assay Journal of Immunological Methods 2001, 254, 85-98.
14. Yun, K., Lee, J., Park, J., Kim, S., Lee, S., Kim, S. H., Lee, J. G., Lee, S. E., Park, J. G., and Yoon, G. S. Detecting nucleic acid hybridization comprises using nucleic acid intercalator, and detect-ing the quantity of light generated. Yun, K., Lee, J., Park, J., Kim, S., Lee, S., and LG ELECTRONICS
INC. [US2003092055-Al; KR2003035247-A].
Sensitive determination of cell number using the CyQUANT (R) cell proliferation assay Journal of Immunological Methods 2001, 254, 85-98.
14. Yun, K., Lee, J., Park, J., Kim, S., Lee, S., Kim, S. H., Lee, J. G., Lee, S. E., Park, J. G., and Yoon, G. S. Detecting nucleic acid hybridization comprises using nucleic acid intercalator, and detect-ing the quantity of light generated. Yun, K., Lee, J., Park, J., Kim, S., Lee, S., and LG ELECTRONICS
INC. [US2003092055-Al; KR2003035247-A].
15. Lee, J. G., Yun, K. S., Park, J. K., Kim, S. H., Kim, T. H., Lee, S.
E., Park, J. G., and Yoon, G.
S. Detecting DNA, for analyzing samples quickly, comprises hybridizing a target with an immobilized DNA probe, fixing an intercalator, introducing electrochemiluminescent fluid, applying a voltage, and analyzing chemiluminescence. LG ELECTRONICS INC. [US2002106682-Al;
KR2002064805-A;
KR386606-13].
E., Park, J. G., and Yoon, G.
S. Detecting DNA, for analyzing samples quickly, comprises hybridizing a target with an immobilized DNA probe, fixing an intercalator, introducing electrochemiluminescent fluid, applying a voltage, and analyzing chemiluminescence. LG ELECTRONICS INC. [US2002106682-Al;
KR2002064805-A;
KR386606-13].
16. Hurley, I. and Rabbani, E. Nucleic acid hybridization assay composition for hybridization assay procedures. ENZO DIAGNOSTICS INC. [US5998135-A; US6239271-B1].
17. Chen, W.; Turro, C.; Friedman, L. A.; Barton, J. K.; Turro, N. J.
Resonance Raman investiga-tion of Ru(phen)(2)(dppz)(2+) and related complexes in water and in the presence of DNA Journal of Physical Chemistry B 1997, 101, 6995-7000.
Resonance Raman investiga-tion of Ru(phen)(2)(dppz)(2+) and related complexes in water and in the presence of DNA Journal of Physical Chemistry B 1997, 101, 6995-7000.
18. Dandliker, P. J.; Holmlin, R. E.; Barton, J. K. Oxidative thymine dimer repair in the DNA helix Science 1997, 275, 1465-68.
19. Erkkila, K. E.; Odom, D. T.; Barton, J. K. Recognition and reaction of metallointercalators with DNA Chemical Reviews 1999, 99, 2777-95.
20. Hill, M. G.; Jackson, N. M.; Barton, J. K.; Kelley, S. 0.
Electrochemistry at DNA-modified sur-faces: Evidence for long-range electron transfer through an extended pi-stack Abstracts of Papers of the American Chemical Society 1997, 214, 144-INOR.
Electrochemistry at DNA-modified sur-faces: Evidence for long-range electron transfer through an extended pi-stack Abstracts of Papers of the American Chemical Society 1997, 214, 144-INOR.
21. Sitlani, A.; Long, E. C.; Pyle, A. M.; Barton, J. K. Dna Photocleavage by Phenanthrenequinone Diimine Complexes of Rhodium(Iii) - Shape-Selective Recognition and Reaction Journal of the Amen-can Chemical Society 1992, 114, 2303-12.
22. Sitlani, A.; Barton, J. K. Sequence-Specific Recognition of Dna by Phenanthrenequinone Diimine Complexes of Rhodium(Iii) - Importance of Steric and Van-Der-Waals Interactions Biochemis-try 1994, 33, 12100-08.
23. Kielkopf, C. L.; Erkkila, K. E.; Hudson, B. P.; Barton, J. K.; Rees, D.
C. Structure of a photo-active rhodium complex intercalated into DNA Nature Structural Biology 2000, 7, 117-21.
C. Structure of a photo-active rhodium complex intercalated into DNA Nature Structural Biology 2000, 7, 117-21.
24. Barton, J. K., Jackson, B. A., and Hudson, B. P. New rhodium intercalating compounds useful for diagnosing and/or treating disorder due to the presence of base mismatches in nucleic acid duplexes.
CALIFORNIA INST OF TECHNOLOGY. [US2003018020-A1; US6777405-B2].
CALIFORNIA INST OF TECHNOLOGY. [US2003018020-A1; US6777405-B2].
25. Dupureur, C. M.; Barton, J. K. Structural studies of Lambda- and Delta-[Ru(phen)(2)dppz](2+) bound to d(GTCGAC)(2): Characterization of enantioselective intercalation Inorganic Chemistry 1997, 36, 33-43.
26. Holmlin, R. E.; Dandliker, P. J.; Hall, D. B.; Barton, J. K. Charge transfer through the DNA
base stack: Chemistry at a distance Abstracts of Papers of the American Chemical Society 1997, 213, 335-INOR.
base stack: Chemistry at a distance Abstracts of Papers of the American Chemical Society 1997, 213, 335-INOR.
27. Barton, J. K., Hill, M. G., and Kelley, S. 0. New composition comprising a nucleic acid duplex which contains one or more electron donor and electron acceptor groups, one of which is an intercalat-ing intercalative, redox-active group for diagnosing genetic diseases.
CALIFORNIA INST OF
TECHNOLOGY. [US6221586-B1].
CALIFORNIA INST OF
TECHNOLOGY. [US6221586-B1].
28. Uchida, K.; Pyle, A. M.; Morii, T.; Barton, J. K. High resolution footprinting of EcoRI and dis-tamycin with Rh(phi)2(bpy)3+, a new photofootprinting reagent Nucleic Acids Res. 1989, 17, 10259-79.
29. Sitlani, A.; Barton, J. K. Shape-Selective Recognition and Reaction by Phenanthrenequinone Diimine Complexes of Rhodium(Iii) Abstracts of Papers of the American Chemical Society 1992, 204, 479-INOR.
30. Chow, C. S.; Hartmann, K. M.; Rawlings, S. L.; Huber, P. W.; Barton, J.
K. Delineation of Structural Domains in Eukaryotic 5S Ribosomal-Rna with A Rhodium Probe Biochemistry 1992, 31, 3534-42.
K. Delineation of Structural Domains in Eukaryotic 5S Ribosomal-Rna with A Rhodium Probe Biochemistry 1992, 31, 3534-42.
31. Chow, C. S.; Behlen, L. S.; Uhlenbeck, 0. C.; Barton, J. K. Recognition of Tertiary Structure in Transfer-Rnas by Rh(Phen)2Phi3+, A New Reagent for Rna Structure-Function Mapping Biochemistry 1992, 31, 972-82.
32. Baranov, V. I.; Quinn, Z.; Bandura, D. R.; Tanner, S. D. A sensitive and quantitative element-tagged immunoassay with ICPMS detection Analytical Chemistry 2002, 74, 1629-36.
33. Baranov, V. I.; Quinn, Z. A.; Bandura, D. R.; Tanner, S. D. The potential for elemental analysis in biotechnology Journal of Analytical Atomic Spectrometry 2002, 17, 1148-52.
34. Zhang, C.; Zhang, Z. Y.; Yu, B. B.; Shi, J. J.; Zhang, X. R.
Application of the biological conju-gate between antibody and colloid Au nanoparticles as analyte to inductively coupled plasma mass spec-trometry Analytical Chemistry 2002, 74, 96-99.
Application of the biological conju-gate between antibody and colloid Au nanoparticles as analyte to inductively coupled plasma mass spec-trometry Analytical Chemistry 2002, 74, 96-99.
35. Quinn, Z. A.; Baranov, V. I.; Tanner, S. D.; Wrana, J. L. Simultaneous determination of pro-teins using an element-tagged immunoassay coupled with ICP-MS detection Journal of Analytical Atomic Spectrometry 2002, /7, 892-96.
36. Li, F. M.; Armstrong, D. W.; Houk, R. S. Behavior of bacteria in the inductively coupled plasma: Atomization and production of atomic ions for mass spectrometry Analytical Chemistry 2005, 77, 1407-13.
37. Zhang, B.; Li, F. M.; Houk, R. S.; Armstrong, D. W. Pore exclusion chromatography-inductively coupled plasma-mass spectrometry for monitoring elements in bacteria: A study on micro-bial removal of uranium from aqueous solution Analytical Chemistry 2003, 75, 6901-05.
38. Binet, M. R. B.; Ma, R. L.; Mcleod, C. W.; Poole, R. K. Detection and characterization of zinc-and cadmium-binding proteins in Escherichia coli by gel electrophoresis and laser ablation-inductively coupled plasma-mass spectrometry Analytical Biochemistry 2003, 318, 30-38.
39. Zhang, Y. S.; Zhang, Z. Y.; Suzuki, K.; Maekawa, T. Uptake and mass balance of trace metals for methane producing bacteria Biomass & Bioenergy 2003, 25, 427-33.
40. Sharma, N. C.; Sahi, S. V.; JaM, J. C. Sesbania drummondii cell cultures: ICP-MS determina-tion of the accumulation of Pb and Cu Microchemical Journal 2005, 81, 163-69.
41. Prange, A.; Profrock, D. Application of CE-ICP-MS and CE-ESI-MS in metalloproteomics:
challenges, developments, and limitations Analytical and Bioanalytical Chemistry 2005, 383, 372-89.
challenges, developments, and limitations Analytical and Bioanalytical Chemistry 2005, 383, 372-89.
42. Ranney, D. F. and Quattrone, A. J. Selective assay of cellular DNA in presence of cell debris -by measuring fluorescence enhancement of fluorochrome in presence of metal ion co-factor. UNIV
TEXAS SYSTEM. [US4423153-A].
TEXAS SYSTEM. [US4423153-A].
43. Muehlbauer, P. A. and Schuler, M. J. Detecting numerical chromosomal abnormalities, e.g.
aneuploidy or polyploidy, by treating a mitotic cell with a mitotic marker and a quantitative DNA stain, and quantifying the amount of DNA in the cell using the quantitative DNA
stain. PFIZER PROD INC, Muehlbauer, P. A., and Schuler, M. J. [W02003046218-A; EP1316619-A; EP1316619-Al;
US2003104461-A1; CA2413177-A1; W02003046218-A1; JP2003210198-A; AU2002347468-Al;
KR2004062979-A; NO200402180-A; CN1606628-A].
aneuploidy or polyploidy, by treating a mitotic cell with a mitotic marker and a quantitative DNA stain, and quantifying the amount of DNA in the cell using the quantitative DNA
stain. PFIZER PROD INC, Muehlbauer, P. A., and Schuler, M. J. [W02003046218-A; EP1316619-A; EP1316619-Al;
US2003104461-A1; CA2413177-A1; W02003046218-A1; JP2003210198-A; AU2002347468-Al;
KR2004062979-A; NO200402180-A; CN1606628-A].
44. Darzynkiewicz, Z., Li, X., and Traganos, F. Labelling DNA strands -using halogenated deoxy-nucleotide triphosphate, enzyme and labelled anti-halogenated deoxy-nucleotide antibody. NEW YORK
MEDICAL, C. 0. L. L., Traganos, F., Li, X., and Darzynkiewicz, Z. [EP851939-A;
W09708345-A;
W09708345-A1; EP851939-Al; US5912126-A].
MEDICAL, C. 0. L. L., Traganos, F., Li, X., and Darzynkiewicz, Z. [EP851939-A;
W09708345-A;
W09708345-A1; EP851939-Al; US5912126-A].
45. Darzynkiewicz, Z. D., Li, X., Traganos, F. N., and Melamed, M. R.
Detection of halogenated precursors incorporated into DNA - useful for prognosis of tumours and evaluation of potential genotox-ins. NEW YORK MEDICAL, C. 0. L. L. [W09533070-A; EP711356-A; W09533070-Al;
AU9526047-A; EP711356-Al; US5747258-A].
Detection of halogenated precursors incorporated into DNA - useful for prognosis of tumours and evaluation of potential genotox-ins. NEW YORK MEDICAL, C. 0. L. L. [W09533070-A; EP711356-A; W09533070-Al;
AU9526047-A; EP711356-Al; US5747258-A].
46. Morrison, D. R. Measuring metastatic activity of tumours - comprises quantitative detection of urokinase and DNA to evaluate the presence of tumour cells with invasive character. NASA US NAT
AERO & SPACE ADMIN. [US5869238-A].
AERO & SPACE ADMIN. [US5869238-A].
47. Bacus, J. W. and Oud, P. S. Kit for quantitation of cell nuclei components - contg. microscope slides having a reference area and a specimen area and containers of stain.
CELL ANALYSIS
SYSTEMS INC and BECTON DICKINSON, C. 0. [EP314293-A2; EP314293-A; JP1127956-A;
US5109429-A; US5272759-A; EP314293-B1; DE3853254-G; US5485527-A].
CELL ANALYSIS
SYSTEMS INC and BECTON DICKINSON, C. 0. [EP314293-A2; EP314293-A; JP1127956-A;
US5109429-A; US5272759-A; EP314293-B1; DE3853254-G; US5485527-A].
48.
Dolbeare, F. A. and Gray, J. W. Flow cytometric or spectrophotometric measurement of total DNA - and incorporated halodeoxyuridine. REGLISSE ZAN, S. A. R. L. [US4780406-A].
Dolbeare, F. A. and Gray, J. W. Flow cytometric or spectrophotometric measurement of total DNA - and incorporated halodeoxyuridine. REGLISSE ZAN, S. A. R. L. [US4780406-A].
49.
Dertinger, S., Torous, D., and Tometsko, K. Method for enumeration of micro-nuclei events in erythrocyte populations - uses single laser flow cytometry on alcohol fixed blood from bone marrow or peripheral blood. LITRON, L. A. B. [US5858667-A].
Dertinger, S., Torous, D., and Tometsko, K. Method for enumeration of micro-nuclei events in erythrocyte populations - uses single laser flow cytometry on alcohol fixed blood from bone marrow or peripheral blood. LITRON, L. A. B. [US5858667-A].
50. Kamentsky, L. D. Cytometric measurement of DNA content of cells to determine cell mitosis -by creating histogram of cell counts versus integrated fluorescent light corrected to remove statistical errors, focusing problems and background. COMPUCYTE CORP. [EP793830-A;
W09611448-A;
W09611448-A1; AU9538889-A; US5633945-A; EP793830-A1; JP10508690-W; 1L115506-4 51. Orfao de Matos Correia e Vale and Orfao de Matos, C. 0. R. R. Cell cycle analysis in heteroge-neous sample - using pool of monoclonal antibodies labelled with same fluorochrome. UNIV
SALAMANCA. [EP798386-A; EP798386-A1; ES2112211-A1; ES2112211-B1; EP798386-B1;
DE69728925-E].
W09611448-A;
W09611448-A1; AU9538889-A; US5633945-A; EP793830-A1; JP10508690-W; 1L115506-4 51. Orfao de Matos Correia e Vale and Orfao de Matos, C. 0. R. R. Cell cycle analysis in heteroge-neous sample - using pool of monoclonal antibodies labelled with same fluorochrome. UNIV
SALAMANCA. [EP798386-A; EP798386-A1; ES2112211-A1; ES2112211-B1; EP798386-B1;
DE69728925-E].
52. Oda, Y., Ishihama, Y., and Tabata, T. Assaying one or more biomolecules in sample, involves adding internal standard substance (metabolically isotope-labeled biomolecule) or cell having internal standard substance, to sample, and measuring sample by mass spectrometer.
EISAI CO LTD and MITSUI KNOWLEDGE IND CO LTD. [W02005050188-A1].
EISAI CO LTD and MITSUI KNOWLEDGE IND CO LTD. [W02005050188-A1].
53. Maeda, M., Akimoto, K., Hori, J., Murayama, R., Tabata, J., and Bando, K. Detecting target gene with specific sequence by adding intercalator to double-stranded nucleic acid formed by adding sample having single-stranded target, to probe, performing photo irradiation and detecting intercalator bound nucleic acid. MATSUSHITA ELECTRIC IND CO LTD and MICROTEC CO LTD.
[W02005103695-A1].
[W02005103695-A1].
54. Barton, J. K. and Junicke, H. New metallo-intercalators useful for e.g. diagnosing genetic disor-ders. CALIFORNIA INST OF TECHNOLOGY, Barton, J. K., and Junicke, H.
[W0200257492-A;
W0200257492-Al; US2002155470-A1; EP1349962-Al; AU2002245116-Al; JP2004522739-W;
US6808884-B2; US2005148772-A1].
[W0200257492-A;
W0200257492-Al; US2002155470-A1; EP1349962-Al; AU2002245116-Al; JP2004522739-W;
US6808884-B2; US2005148772-A1].
Claims (7)
1. A method to determine DNA content and antigen content per cell in a sample of cells, comprising:
(a) determining the number of cells in the sample;
(b) fixing and permeabilizing of the cells;
(c) incubating the sample of cells with an intercalator tagged with a first element under conditions appropriate to incorporate the intercalator into the DNA within the cells of the sample;
(d) removing unbound intercalator from the cells;
(e) incubating antigen specific affinity products labeled with a second element tag with the cells;
(f) removing unbound affinity products from the cells;
(g) simultaneously measuring the intercalator tagged with the first element and the affinity product labeled with the second element tag by elemental analysis using an inductively coupled plasma mass spectrometer for determining the amount of the first element and the amount of the second element; and (h) calculating the DNA content and the antigen content per cell from the amount of the first element and from the amount of the second element respectively.
(a) determining the number of cells in the sample;
(b) fixing and permeabilizing of the cells;
(c) incubating the sample of cells with an intercalator tagged with a first element under conditions appropriate to incorporate the intercalator into the DNA within the cells of the sample;
(d) removing unbound intercalator from the cells;
(e) incubating antigen specific affinity products labeled with a second element tag with the cells;
(f) removing unbound affinity products from the cells;
(g) simultaneously measuring the intercalator tagged with the first element and the affinity product labeled with the second element tag by elemental analysis using an inductively coupled plasma mass spectrometer for determining the amount of the first element and the amount of the second element; and (h) calculating the DNA content and the antigen content per cell from the amount of the first element and from the amount of the second element respectively.
2. The method of claim 1 where in step (a) the number of cells is calculated using a hemocytometer or a Coulter counter.
3. The method of claim 1 where in step (e) the antigen specific affinity product is an antibody complex comprising a secondary antibody labeled with an element tag that binds to a primary antibody, and wherein the primary antibody is specific to the antigen.
4. The method of claim 1 where in step (e) the cells are incubated with at least two classes of antibodies, each class of antibodies specific to different classes of antigens and each class of antibody is labeled with unique element tag.
5. The method of claim 1 further comprising a step after step (e) wherein the cells are dissolved to generate a relatively homogeneous sample before determining the amount of the first element and the amount of the second element by performing solution elemental analysis.
6. The method of claim 5 wherein the cells are dissolved in an acid solution.
7. The method of claim 1 where in steps (a) and (g) a mass spectrometer-based flow cytometer is used.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77258906P | 2006-02-13 | 2006-02-13 | |
US60/772,589 | 2006-02-13 | ||
PCT/CA2007/000221 WO2007140571A1 (en) | 2006-02-13 | 2007-02-13 | Quantitation of cellular dna and cell numbers using element labeling |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2642575A1 CA2642575A1 (en) | 2007-12-13 |
CA2642575C true CA2642575C (en) | 2015-01-20 |
Family
ID=38800988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2642575A Active CA2642575C (en) | 2006-02-13 | 2007-02-13 | Quantitation of cellular dna and cell numbers using element labeling |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2642575C (en) |
WO (1) | WO2007140571A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3561071B1 (en) | 2006-02-13 | 2020-12-16 | Fluidigm Canada Inc. | Gene expression assays conducted by elemental analysis |
CA2658787C (en) | 2006-08-15 | 2013-04-09 | Alexei Antonov | Apparatus and method for elemental analysis of particles by mass spectrometry |
US9218949B2 (en) | 2013-06-04 | 2015-12-22 | Fluidigm Canada, Inc. | Strategic dynamic range control for time-of-flight mass spectrometry |
WO2020235424A1 (en) * | 2019-05-17 | 2020-11-26 | 株式会社島津製作所 | Method for detecting extracellular vesicles |
CN112710829A (en) * | 2020-12-18 | 2021-04-27 | 北京清分稳同科技有限公司 | Novel element mass spectrometry detection kit for coronavirus IgG antibody |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4585736A (en) * | 1983-10-18 | 1986-04-29 | The United States Of America As Represented By The United States Department Of Energy | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine |
US7479630B2 (en) * | 2004-03-25 | 2009-01-20 | Bandura Dmitry R | Method and apparatus for flow cytometry linked with elemental analysis |
-
2007
- 2007-02-13 CA CA2642575A patent/CA2642575C/en active Active
- 2007-02-13 WO PCT/CA2007/000221 patent/WO2007140571A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007140571A1 (en) | 2007-12-13 |
CA2642575A1 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8354242B2 (en) | Quantitation of cellular DNA and cell numbers using element labeling | |
Liu et al. | Inductively coupled plasma mass spectrometry‐based immunoassay: A review | |
Ornatsky et al. | Multiple cellular antigen detection by ICP-MS | |
TW316291B (en) | ||
Harma et al. | Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen | |
Hao et al. | Mapping of heavy metal ion sorption to cell-extracellular polymeric substance-mineral aggregates by using metal-selective fluorescent probes and confocal laser scanning microscopy | |
Scorilas et al. | Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays | |
Hu et al. | Single nanoparticle analysis by ICPMS: a potential tool for bioassay | |
Tanner et al. | Multiplex bio-assay with inductively coupled plasma mass spectrometry: towards a massively multivariate single-cell technology | |
US7364872B1 (en) | Test methods using enzymatic deposition and alteration of metals | |
CA2642575C (en) | Quantitation of cellular dna and cell numbers using element labeling | |
EP2269065B1 (en) | Methods and reagents to increase the sensitivity of enzyme metallographic detection | |
JPH03182562A (en) | Compound for quantitative measurement of reticular erythrocyte in whole blood, reagent composition and its use | |
CN105548585A (en) | Lipoprotein analysis by differential charged-particle mobility | |
US20120058548A1 (en) | Detection of biotargets using bioreceptor functionalized nanoparticles | |
US9739765B2 (en) | Metal-based covalent viability reagent for single cell analysis | |
US20110020799A1 (en) | Screening method for damaged DNA repairing substance | |
HRP20040488A2 (en) | Methods for detecting cells with numerical chromosomal abnormalities | |
EP1658497A1 (en) | A method and kit for the quantitative and/or qualitative detection of components in a sample | |
Chen et al. | Lanthanide nanoprobes for the multiplex evaluation of breast cancer biomarkers | |
Zhang et al. | FeS2− AuNPs nanocomposite as mimicking enzyme for constructing signal‐off sandwich‐type electrochemical immunosensor based on electroactive nickel hexacyanoferrate as matrix | |
Zhang et al. | An ultrasensitive electrochemical aptasensor for microcystin-LR detection using core-satellite gold nanoparticle/silver nanocluster nanoassemblies as labels for signal amplification | |
JP2001506686A (en) | Helium-neon excitable reticulocyte staining dye derivable from halorepidine | |
US20220381775A1 (en) | Analyte detection and quantification by discrete enumeration of particle complexes | |
Zhang et al. | An enzyme substrate binding aptamer complex based time-resolved fluorescence sensor for the adenosine deaminasedetection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |